Healthcare Fund Gp Llc Fairmount serves as Executive at Viridian Therapeutics, Inc.\DE, where they oversee executive responsibilities. Since joining the company, Healthcare Fund Gp Llc Fairmount has executed 1 insider transactions totaling $10.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 17, 2022 involved purchasing 425,531 shares valued at $10.0M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 17, 2022 | VRDN | $10.0M | Purchase | 425,531 | $23.50 | Discretionary |
Healthcare Fund Gp Llc Fairmount currently holds 1,363,764 shares of Viridian Therapeutics, Inc.\DE (VRDN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Healthcare Fund Gp Llc Fairmount has been a net buyer of VRDN stock. They have purchased $10.0M and sold $0 worth of shares.
Healthcare Fund Gp Llc Fairmount's most recent insider trade was on Aug 17, 2022, when they purchased 425,531 shares at $23.50 per share.
Get notified when new Form 4 filings are submitted